Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide doses are prescribed in milligrams (mg), not millilitres (ml), but the two figures are directly related — each Wegovy pen delivers a fixed volume that contains the prescribed mg dose. If you are trying to convert a semaglutide dose in ml to understand your injection or compare devices, the short answer is that Wegovy's pre-filled pens are factory-set: you do not measure or draw up a volume yourself. The pen clicks to the correct amount automatically. These are prescription-only medicines, and the dose your prescriber selects is based on a clinical assessment of your individual circumstances — not a volume you calculate at home.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When a medicine is injected, two numbers matter: how much active drug is present (the dose, in mg or micrograms) and how much liquid carries it (the volume, in ml). For most patients taking Wegovy, only the mg figure appears on the pen or in any communication from their prescriber. That is deliberate. The manufacturer (Novo Nordisk) fixes the concentration of semaglutide in the liquid, so a known volume always delivers a known dose. You do not need to measure anything.
To put a figure on it: the Wegovy injection pens use a concentration of 1.34 mg/ml for the lower doses, meaning a 0.25 mg dose is delivered in roughly 0.19 ml of solution. These numbers come from the product's Summary of Product Characteristics, which you can review in full via the semaglutide entry on the eMC (Electronic Medicines Compendium). For everyday use, though, none of this arithmetic is necessary, the pen does it for you.
Questions about how the semaglutide dosing schedule works are among the most common ones our prescribers hear, and the consistent answer is the same: the mg figure on your prescription is the clinically meaningful number. Volume is manufacturing detail.
The licensed Wegovy injection pathway titrates upward in stages. The dose begins at 0.25 mg to allow your body to settle, rises to 0.5 mg, then 1.0 mg, then 1.7 mg, and reaches the standard 2.4 mg maintenance dose after approximately four to five months. The MHRA approved a 7.2 mg dose in January 2026, with a dedicated single-dose pen confirmed in April 2026, the highest semaglutide dose available anywhere in the world.
Across this range, the injected volume per dose stays modest, typically under half a millilitre for the lower steps. If you want to understand the ml-to-mg relationship in more detail, our guide to converting semaglutide ml to mg works through the arithmetic clearly. The NHS also publishes patient-level information about semaglutide on its medicines pages, including what to expect from each pen, see the NHS semaglutide medicines page for reference.
One thing worth knowing: the 7.2 mg pen works differently from the lower-dose pens in its delivery mechanism, it has an auto-dosing design with a built-in covered needle that locks after use. Confirming which pen format and dose are available to you is something our team does at the point of your clinical assessment; it is not something to rely on a product listing to establish.
This is where real confusion creeps in. Compounded or unlicensed semaglutide products (typically sold outside regulated pharmacy channels) are sometimes described in units per ml, or in volumes like 0.25 ml or 0.5 ml, without a clear mg concentration stated. That framing makes it almost impossible to know whether you are comparing like for like with a licensed Wegovy pen, and it is one reason the MHRA has repeatedly warned about the risks of buying these medicines without a prescription from a pharmacist you can verify.
For anyone looking at the full range of semaglutide doses available in the UK, the safest frame of reference is always the licensed product's prescribing information. If a source is quoting your dose purely in ml with no mg equivalent stated, that is worth raising with a clinician.
You can check whether any online pharmacy dispensing these medicines is properly registered by searching the GPhC pharmacy register. Our GPhC premises registration number is 9012878, verifiable there directly. It is the kind of detail that takes thirty seconds to check and genuinely matters for a prescription medicine.
Yes, it does, though the change is small and the pen handles it automatically. As the mg dose increases, the volume injected increases proportionally within each pen's concentration range. You will not notice a dramatic difference, this is not like switching between two visually distinct syringes. The pen simply delivers a slightly larger amount of liquid at each titration step.
Some patients transitioning to Wegovy from a different semaglutide-containing product ask whether the volumes are equivalent. They are not always directly comparable because the formulation and concentration can differ. Our page on the semaglutide 2 mg dose covers that transition territory in more detail. Similarly, if you are curious about lower-dose volumes specifically, the breakdown for the 1 mg semaglutide dose is worth reading.
For the full clinical picture of how Wegovy works as a treatment, including what to expect at each stage of the schedule, our Wegovy overview covers the licensed indications, the evidence base and the access routes. If you are weighing up the different Wegovy dose options before a consultation, that page will help you arrive with the right questions. And if you are ready to find out whether Wegovy could be right for you, starting a free consultation with our prescribers is the clearest next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.